Coya Therapeutics, Inc. Common Stock

COYANASDAQ • USD
ThemeBiotech - Drug Development›Neuroscience & CNS
5.04 USD
↗ 0.08 (1.61%)AT CLOSE (11:59 AM EDT)
5.06
↗ 0.02 (0.40%)
POST MARKET (AS OF 06:56 PM EDT)
Post Market
AS OF 06:56 PM EDT
5.06
↗ 0.02 (0.40%)
🟢Market: OPEN

Coya Therapeutics, Inc. Common Stock (COYA) is currently trading at $5.06. Technicals currently rate "Strong Buy" while our fundamental analysis reads "Neutral". Key drivers include a robust Altman Z-Score, a weak Piotroski F-Score of 2/9, negative Return on Equity and a bearish Death Cross on the long-term moving averages. COYA is fairly valued relative to its sector peers based on current multiples.

Technical & fundamental data as of Aug 25, 2026.

Open?$4.99
High?$5.22
Low?$4.98
Prev. Close?$4.96
Volume?145.2K
Avg. Volume?171.5K
VWAP?$5.09
Rel. Volume?0.85x
Bid / Ask
Bid?$4.36 × 100
Ask?$5.78 × 100
Spread?$1.42
Midpoint?$5.07
Valuation & Ratios
Market Cap?116.4M
Shares Out?23.5M
Float?18.3M
Float %?77.8%
P/E Ratio?N/A
P/B Ratio?2.69
EPS?-$0.92
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary new therapies to enhance the function of regulatory T cells (Tregs). The company's initial development programs are focused on neurodegenerative, chronic inflammatory, autoimmune, and metabolic diseases with high unmet medical needs.
Themes
Biotech - Drug Development›Neuroscience & CNSBiotech - Drug Development›Immunology & Autoimmune
Employees
8
Market Cap
116.4M
Industry
PHARMACEUTICAL PREPARATIONS
Website
www.coyatherapeutics.com
Listed
2022-12-29
Address
12645 MEMORIAL DR., SUITE F1 #305
HOUSTON, TX 77024
Phone: 650.739.3939
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+2/3)
Medium-Term (Wave)?▲ Bullish(+2/3)
Short-Term (Ripple)?▲ Bullish(+3/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
12
Z-Score?
100
Momentum?
65
Short Sent.?
42
Piotroski F-Score?2/9Weak
Altman Z-Score?14.73Safe
Confidence?46%Low
Full Fundamental Analysis →
Short InterestHigh
Short % of Float?5.79%Elevated
Short Interest?1.1M
Days to Cover?7.8
Free Float18.3M
Avg Daily Volume135.0K
Settlement Date2026-08-14
Financial Health
Current Ratio?13.40Strong
Quick Ratio?13.40Strong
Cash Ratio?12.29Strong
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
67/100
P/E?
N/A▾
P/B?
Peers
100
S&P
61
2.69CHEAP▾
P/S?
Peers
100
S&P
3
14.51HIGH▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-3.2CHEAP▾
EV/Sales?
Peers
100
S&P
13
9.12HIGH▾
Returns & Efficiency
ROE?
S&P
3
-50.1%WEAK▾
ROA?
S&P
3
-45.8%WEAK▾
Cash Flow & Enterprise
FCF?$-15722176
Enterprise Value?$73.2M
Fundamentals ratios updated end of day
MarketsMoversWatchlist